Journal: Molecular & Cellular Proteomics : MCP
Article Title: ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells
doi: 10.1016/j.mcpro.2025.100964
Figure Lengend Snippet: Proteomic analysis of WT, inhibitor-treated, and ERAP1 KO A375 cells. Panel A , heat map showing the cluster analysis and distribution of proteins in the three conditions (WT, inhibitor-treated, and ERAP1 KO A375 cells) for each replicate (four biological replicates, each measured in three technical replicates) (graph generated with Perseus v. 1.6.15). Panel B , principal component analysis (PCA) of the three experimental conditions. Each point represents a distinct biological or technical replicate. Panels C and D , Hawaii plots of identified proteins, indicating the statistical significance of the observed differences in protein abundance between the two treatment conditions (inhibitor-treated and ERAP1 KO) and the WT cells. Three hundred twenty-five proteins in the inhibitor-treated ( C ) and 1095 proteins in the KO cells ( D ) were differentially expressed. Select proteins that participate in antigen presentation are indicated in red (graph generated with Perseus v. 1.6.15). Panels E , F , and G , heat maps of proteins participating in protein folding ( E ), proteasomal protein catabolic process ( F ), and protein processing in the endoplasmic reticulum ( G ) (graphs generated with Perseus v. 1.6.15). ERAP, endoplasmic reticulum aminopeptidase.
Article Snippet: THP-1 WT (TIB-202, American Type Culture Collection) and THP-1 ERAP1 KO cells, generated in Dr Doriana Fruci’s lab at Ospedale Pediatrico Bambino Gesù (Król et al , manuscript in preparation), were cultured in Rosswell Park Memorial Institute 1640 (Biowest, L0501) with the addition of 10% FBS (Biowest, S1810), 2 mM L-glutamine (Biowest, X0550), and 1% Penicillin-Streptomycin (Biowest, L022) as usual at 37 °C, 5% CO 2.
Techniques: Generated, Quantitative Proteomics, Immunopeptidomics